Latest healthtech and biotech deals
The largest from last week:
🇺🇸 R-Zero, biosafety technology company that automatically disinfects air and surfaces, raised $125M to accelerate product development.
🇫🇷 Owkin, a collaborative research platform that allows doctors, medical researchers, and pharmaceutical companies to identify new drug candidates, and enhance clinical trials, raised $80M in Series B. Owkin will use the investment to support its data generation strategy in multiple therapeutic areas with a strong focus on multimodal and rich biological data.
🇬🇧 Proximie, British healthtech startup that uses augmented reality tech for surgeons to advise on operations remotely around the world, raised $80M in Series C. Proximie has already secured several high-value contracts, including one with Vodafone (which runs a health solutions arm) and Teladoc. It’s also signed deals with several medical device providers. The new fundraising will be used to expand Proximie’s platform.
Other notable deals from around the globe:
🇺🇸 Sana Benefits, a healthcare company that provides health benefits to small businesses at affordable prices, raised $60M in Series B.
🇺🇸 Ever/Body, digital company offering cosmetic dermatology services, raised $55M in Series C. The company intends to use the funds for national expansion, further advancements in technology, and the acceleration of a proprietary education program for providers.
🇩🇪 Cara Care, digital gut health platform, raised €6.6M. Just months after being approved onto Germany’s DiGA programme, Cara Care plans to branch out into France and broaden its portfolio of digital therapeutics.
Read up on all the latest health deals in Dealroom.co